Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis (Q92242280)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2020
edit
Language Label Description Also known as
English
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
scientific article published on 01 January 2020

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit